Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models

Neuroscience and Biobehavioral Reviews

Volumn 65, Issue , 2016, Pages 292-312

  Homberg, Judith R ^a   Kyzar, Evan J ^b,c   Nguyen, Michael ^c,d   Norton, William H ^e   Pittman, Julian ^f   Poudel, Manoj K ^c   Gaikwad, Siddharth ^c   Nakamura, Shun ^g   Koshiba, Mamiko ^h   Yamanouchi, Hideo ^h   Scattoni, Maria Luisa ⁱ   Ullman, Jeremy F P ^j   Diamond, David M ^k,l   Kaluyeva, Aleksandra A ^c   Parker, Matthew O ^m   Klimenko, Victor M ⁿ   Apryatin, Sergey A ^o   Brown, Richard E ^p   Song, Cai ^p,q,r   Gainetdinov, Raul R ^s,t   Gottesman, Irving I ^u   Kalueff, Allan V ^q,s,v   more..

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ILLINOIS   (United States)

^c The International Stress and Behavior Society (ISBS) and ZENEREI Research Center   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f TROY UNIVERSITY   (United States)

^g TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁱ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^j UNIVERSITY OF QUEENSLAND   (Australia)

^k UNIVERSITY OF SOUTH FLORIDA   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF PORTSMOUTH   (United Kingdom)

ⁿ INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^o FEDERAL RESEARCH CENTRE OF NUTRITION   (Russian Federation)

^p DALHOUSIE UNIVERSITY   (Canada)

^q GUANGDONG OCEAN UNIVERSITY   (China)

^r CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^s ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^t SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^u UNIVERSITY OF MINNESOTA   (United States)

^v URAL FEDERAL UNIVERSITY   (Russian Federation)

more..

Author keywords

Experimental model; Model organism; Neurodevelopmental disorder; Preclinical study; Translational research

Indexed keywords

MONOAMINE DERIVATIVE; OXIDOPAMINE;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIORAL INFLEXIBILITY; BEHAVIORAL RESEARCH; COGNITIVE DEVELOPMENT; COMORBIDITY; COMPULSION; DAT GENE; EMOTION; ENVIRONMENTAL ENRICHMENT; EXPERIMENTAL ANIMAL; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL TRANSLATIONAL NEUROBEHAVIORAL MODEL; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTEREST RESTRICTION; LEARNING AND MEMORY TEST; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGICAL MODEL; REVIEW; SEIZURE; SNAP25 GENE; SOCIAL BEHAVIOR; ANIMAL; BRAIN; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT;

ANIMALS; AUTISM SPECTRUM DISORDER; AUTISTIC DISORDER; BRAIN; NEURODEVELOPMENTAL DISORDERS; NEUROGENESIS;

EID: 84963894206     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.03.013     Document Type: Review

References (330)

1. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders: DSM-5 2013, APA, Washington, D.C. 5th ed.
2. Alleva E., Laviola G., Tirelli E., Bignami G. Short- medium-, and long-term effects of prenatal oxazepam on neurobehavioural development of mice. Psychopharmacology (Berl.) 1985, 87:434-441.
3. Altamura C., Dell'Acqua M.L., Moessner R., Murphy D.L., Lesch K.P., Persico A.M. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb. Cortex 2007, 17:1394-1401.
4. Amendola J., Verrier B., Roubertoux P., Durand J. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2004, 20:2822-2826.
5. Amodeo D.A., Yi J., Sweeney J.A., Ragozzino M.E. Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf/J mice. Front. Synaptic Neurosci. 2014, 6:17.
6. Antrop I., Roeyers H., Van Oost P., Buysse A. Stimulation seeking and hyperactivity in children with ADHD. Attention deficit hyperactivity disorder. J. Child Psychol. Psychiatrys 2000, 41:225-231.
7. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domene S., Velez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londono A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos-Quiroga J.A., Hervas A., Maher B.S., Faraone S.V., Seitz C., Freitag C.M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey-Wilson J.E., Castellanos F.X., Muenke M. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15:1053-1066.
8. Argyropoulos A., Gilby K.L., Hill-Yardin E.L. Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front. Human Neurosci. 2013, 7:417.
9. Bader P.L., Faizi M., Kim L.H., Owen S.F., Tadross M.R., Alfa R.W., Bett G.C., Tsien R.W., Rasmusson R.L., Shamloo M. Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15432-15437.
10. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., Nemeroff C.B., Reyes T.M., Simerly R.B., Susser E.S., Nestler E.J. Early life programming and neurodevelopmental disorders. Biol. Psychiatry 2010, 68:314-319.
11. Barr A.M., Lehmann-Masten V., Paulus M., Gainetdinov R.R., Caron M.G., Geyer M.A. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 2004, 29:221-228.
12. Bergner C.L., Smolinsky A.N., Hart P.C., Dufour B.D., Egan R.J., Laporte J.L., Kalueff A.V. Mouse models for studying depression-like states and antidepressant drugs. Methods Mol. Biol. 2010, 602:267-282.
13. Berridge K.C., Aldridge J.W., Houchard K.R., Zhuang X. Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol. 2005, 3:4.
14. Bishop S.L., Lahvis G.P. The autism diagnosis in translation: shared affect in children and mouse models of ASD. Autism Res. 2011, 4:317-335.
15. Blaney C.E., Gunn R.K., Stover K.R., Brown R.E. Maternal genotype influences behavioral development of 3xTg-aD mouse pups. Behav. Brain Res. 2013, 252:40-48.
16. Blaser R.E., Chadwick L., McGinnis G.C. Behavioral measures of anxiety in zebrafish (Danio rerio). Behav. Brain Res. 2010, 208:56-62.
17. Blin M., Norton W., Bally-Cuif L., Vernier P. NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain. Mol. Cell. Neurosci. 2008, 39:592-604.
18. Bloom B., Jones L., Freeman G. Summary Health Statistics for U.S. Children: National Health Interview Survey 2012 2013, US Government Printing Office.
19. Blundell J., Tabuchi K., Bolliger M.F., Blaiss C.A., Brose N., Liu X., Sudhof T.C., Powell C.M. Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav. 2009, 8:114-126.
20. Bolivar V.J., Brown R.E. The ontogeny of ultrasonic vocalizations and other behaviors in male jimpy (jp/Y) mice and their normal male littermates. Dev. Psychobiol. 1994, 27:101-110.
21. Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
22. Boyer B.E., Geurts H.M., Prins P.J., Van der Oord S. One-year follow-up of two novel CBTs for adolescents with ADHD. Eur. Child Adolesc. Psychiatry 2015, 24:1075-1090.
23. Bozdagi O., Sakurai T., Papapetrou D., Wang X., Dickstein D.L., Takahashi N., Kajiwara Y., Yang M., Katz A.M., Scattoni M.L., Harris M.J., Saxena R., Silverman J.L., Crawley J.N., Zhou Q., Hof P.R., Buxbaum J.D. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 2010, 1:15.
24. Branchi I., Ricceri L. Transgenic and knock-out mouse pups: the growing need for behavioral analysis. Genes Brain Behav. 2002, 1:135-141.
25. Branchi I., D'Andrea I., Cirulli F., Lipp H.P., Alleva E. Shaping brain development: mouse communal nesting blunts adult neuroendocrine and behavioral response to social stress and modifies chronic antidepressant treatment outcome. Psychoneuroendocrinology 2010, 35:743-751.
26. Brodkin J., Frank D., Grippo R., Hausfater M., Gulinello M., Achterholt N., Gutzen C. Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice. J. Neurosci. Methods 2014, 224:48-57.
27. Bronfeld M., Israelashvili M., Bar-Gad I. Pharmacological animal models of Tourette syndrome. Neurosci. Biobehav. Rev. 2013, 37:1101-1119.
28. Brophy K., Hawi Z., Kirley A., Fitzgerald M., Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol. Psychiatry 2002, 7:913-917.
29. Brown R.E., Willner J.A. Establishing an affective scale for odor preferences of infant rats. Behav. Neural Biol. 1983, 38:251-260.
30. Broxup B., Robinson K., Losos G., Beyrouty P. Correlation between behavioral and pathological changes in the evaluation of neurotoxicity. Toxicol. Appl. Pharmacol. 1989, 101:510-520.
31. Bruno K.J., Freet C.S., Twining R.C., Egami K., Grigson P.S., Hess E.J. Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol. Dis. 2007, 25:206-216.
32. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 2009, 35:383-402.
33. Buelke-Sam J., Kimmel C.A. Development and standardization of screening methods for behavioral teratology. Teratology 1979, 20:17-29.
34. Burket J.A., Benson A.D., Tang A.H., Deutsch S.I. D-cycloserine improves sociability in the BTBR T+ Itpr3tf/: J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling. Brain Res. Bull. 2013, 96:62-70.
35. Butcher R.E. Behavioral testing as a method for assessing risk. Environ. Health Perspect. 1976, 18:75-78.
36. Cachat J.M., Canavello P.R., Elegante M.F., Bartels B.K., Elkhayat S.I., Hart P.C., Tien A.K., Tien D.H., Beeson E., Mohnot S. Modeling Stress and Anxiety in Zebrafish, Zebrafish Models in Neurobehavioral Research 2011, 73-88. Springer.
37. Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996, 16:297-307.
38. Casey B.J., Craddock N., Cuthbert B.N., Hyman S.E., Lee F.S., Ressler K.J. DSM-5 and RDoC: progress in psychiatry research?. Nat. Rev. Neurosci. 2013, 14:810-814.
39. Castellan Baldan L., Williams K.A., Gallezot J.D., Pogorelov V., Rapanelli M., Crowley M., Anderson G.M., Loring E., Gorczyca R., Billingslea E., Wasylink S., Panza K.E., Ercan-Sencicek A.G., Krusong K., Leventhal B.L., Ohtsu H., Bloch M.H., Hughes Z.A., Krystal J.H., Mayes L., de Araujo I., Ding Y.S., State M.W., Pittenger C. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron 2014, 81:77-90.
40. Chameau P., Inta D., Vitalis T., Monyer H., Wadman W.J., van Hooft J.A. The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7227-7232.
41. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
42. Chen Y.H., Rodgers J., McConachie H. Restricted and repetitive behaviours, sensory processing and cognitive style in children with autism spectrum disorders. J. Autism Dev. Disord. 2009, 39:635-642.
43. Chen T.H., Wang Y.H., Wu Y.H. Developmental exposures to ethanol or dimethylsulfoxide at low concentrations alter locomotor activity in larval zebrafish: implications for behavioral toxicity bioassays. Aquatic Toxicol. (Amsterdam, Netherlands) 2011, 102:162-166.
44. Chen X., Ye R., Gargus J.J., Blakely R.D., Dobrenis K., Sze J.Y. Disruption of transient serotonin accumulation by non-serotonin-producing neurons impairs cortical map development. Cell Rep. 2015, S2211:1062-1066.
45. Cohen I.L., Gardner J.M., Karmel B.Z., Kim S.Y. Rating scale measures are associated with Noldus EthoVision-XT video tracking of behaviors of children on the autism spectrum. Mol. Autism. 2014, 5(1):15.
46. Colacicco G., Welzl H., Lipp H.P., Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav. Brain Res. 2002, 132:95-102.
47. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
48. Corkum P., Tannock R., Moldofsky H., Hogg-Johnson S., Humphries T. Actigraphy and parental ratings of sleep in children with attention-deficit/hyperactivity disorder (ADHD). Sleep 2001, 24:303-312.
49. Courtet P., Gottesman I.I., Jollant F., Gould T.D. The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?. Transl. Psychiatry 2011, 1.
50. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav. 1981, 15:695-699.
51. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:248-258.
52. Crawley J.N. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. (Zurich, Switzerland) 2007, 17:448-459.
53. Creese I., Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 1975, 83:419-436.
54. Crofton K.M. Reflex modification and the assessment of sensory dysfunction. Target Organ Toxicol. Series 1992, 1992.
55. Cromwell H.C., Berridge K.C., Drago J., Levine M.S. Action sequencing is impaired in D1A-deficient mutant mice. Eur. J. Neurosci. 1998, 10:2426-2432.
56. Crossley N.A., Mechelli A., Scott J., Carletti F., Fox P.T., McGuire P., Bullmore E.T. The hubs of the human connectome are generally implicated in the analomy of brain disorders. Brain 2014, 1-14.
57. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 2005, 4:775-790.
58. Cryan J.F., Slattery D.A. Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 2007, 20:1-7.
59. Cuomo V., De Salvia M.A., Petruzzi S., Alleva E. Appropriate end points for the characterization of behavioral changes in developmental toxicology. Environ. Health Perspect. 1996, 104(Suppl. 2):307-315.
60. Cuthbert B.N., Insel T.R. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr. Bull. 2010, 36:1061-1062.
61. Davids E., Zhang K., Tarazi F.I., Baldessarini R.J. Animal models of attention-deficit hyperactivity disorder. Brain Res. Brain Res. Rev. 2003, 42:1-21.
62. De Filippis B., Ricceri L., Laviola G. Early postnatal behavioral changes in the Mecp 2-308 truncation mouse model of Rett syndrome. Genes Brain Behav. 2010, 9:213-223.
63. De Villiers A.S., Russell V.A., Sagvolden T., Searson A., Jaffer A., Taljaard J.J. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem. Res. 1995, 20:427-433.
64. DeLorey T.M., Handforth A., Anagnostaras S.G., Homanics G.E., Minassian B.A., Asatourian A., Fanselow M.S., Delgado-Escueta A., Ellison G.D., Olsen R.W. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 1998, 18:8505-8514.
65. Deakin J.F., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. (Oxf.) 1991, 5:305-315.
66. Denys D., de Vries F., Cath D., Figee M., Vulink N., Veltman D.J., van der Doef T.F., Boellaard R., Westenberg H., van Balkom A., Lammertsma A.A., van Berckel B.N. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur. Neuropsychopharmacol. 2013, 23:1423-1431.
67. Deoni S.C., Zinkstok J.R., Daly E., Ecker C., Consortium M.A., Williams S.C., Murphy D.G. White-matter relaxation time and myelin water fraction differences in young adults with autism. Psychol. Med. 2015, 45:795-805.
68. Ding B. Gene expression in maturing neurons: regulatory mechanisms and related neurodevelopmental disorders. Sheng Li Xue Bao: [Acta physiologica Sinica] 2015, 67:113-133.
69. Ditzen C., Tang N., Jastorff A.M., Teplytska L., Yassouridis A., Maccarrone G., Uhr M., Bronisch T., Miller C.A., Holsboer F., Turck C.W. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 2012, 37:1013-1025.
70. Dufour B.D., Adeola O., Cheng H.W., Donkin S.S., Klein J.D., Pajor E.A., Garner J.P. Nutritional up-regulation of serotonin paradoxically induces compulsive behavior. Nutr. Neurosci. 2010, 13:256-264.
71. Duncan L.E., Pollastri A.R., Smoller J.W. Mind the gap: why many geneticists and psychological scientists have discrepant views about gene-environment interaction (GxE) research. Am. Psychol. 2014, 69:249-268.
72. Dykens E.M. Family adjustment and interventions in neurodevelopmental disorders. Curr. Opin. Psychiatry 2015, 28:121-126.
73. Ehret G. Infant rodent ultrasounds-a gate to the understanding of sound communication. Behav. Genet. 2005, 35:19-29.
74. Elmazar M.M., Sullivan F.M. Effect of prenatal phenytoin administration on postnatal development of the rat: a behavioral teratology study. Teratology 1981, 24:115-124.
75. Elsabbagh M., Gliga T., Pickles A., Hudry K., Charman T., Johnson M.H. The development of face orienting mechanisms in infants at-risk for autism. Behav. Brain Res. 2013, 251:147-154.
76. Elwood R.W., Keeling F. Temporal organization of ultrasonic vocalizations in infant mice. Dev. Psychobiol. 1982, 15:221-227.
77. Ey E., Torquet N., Le Sourd A.M., Leblond C.S., Boeckers T.M., Faure P., Bourgeron T. The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations. Behav. Brain Res. 2013, 256:677-689.
78. Fassio A., Raimondi A., Lignani G., Benfenati F., Baldelli P. Synapsins: from synapse to network hyperexcitability and epilepsy. Semin. Cell Dev. Biol. 2011, 22:408-415.
79. Felling R.J., Singer H.S. Neurobiology of tourette syndrome: current status and need for further investigation. J. Neurosci. 2011, 31:12387-12395.
80. Feyder M., Karlsson R.M., Mathur P., Lyman M., Bock R., Momenan R., Munasinghe J., Scattoni M.L., Ihne J., Camp M., Graybeal C., Strathdee D., Begg A., Alvarez V.A., Kirsch P., Rietschel M., Cichon S., Walter H., Meyer-Lindenberg A., Grant S.G., Holmes A. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am. J. Psychiatry 2010, 167:1508-1517.
81. Filiou M.D., Zhang Y., Teplytska L., Reckow S., Gormanns P., Maccarrone G., Frank E., Kessler M.S., Hambsch B., Nussbaumer M., Bunck M., Ludwig T., Yassouridis A., Holsboer F., Landgraf R., Turck C.W. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol. Psychiatry 2011, 70:1074-1082.
82. Fox M. Neuro-ontogeny of neuromuscular mutant mice. J. Hered. 1965, 56:55-60.
83. Frederick A.L., Stanwood G.D. Drugs, biogenic amine targets and the developing brain. Dev. Neurosci. 2009, 31:7-22.
84. Frith U., Morton J., Leslie A.M. The cognitive basis of a biological disorder: autism. Trends Neurosci. 1991, 14:433-438.
85. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res. Brain Res. Rev. 1998, 26:148-153.
86. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
87. Gandal M.J., Sisti J., Klook K., Ortinski P.I., Leitman V., Liang Y., Thieu T., Anderson R., Pierce R.C., Jonak G., Gur R.E., Carlson G., Siegel S.J. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl. Psychiatry 2012, 2:e142.
88. Garner J.P., Weisker S.M., Dufour B., Mench J.A. Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comp. Med. 2004, 54:216-224.
89. Garner J.P., Thogerson C.M., Wurbel H., Murray J.D., Mench J.A. Animal neuropsychology: validation of the Intra-dimensional extra-dimensional set shifting task for mice. Behav. Brain Res. 2006, 173:53-61.
90. Garner J.P., Thogerson C.M., Dufour B.D., Wurbel H., Murray J.D., Mench J.A. Reverse-translational biomarker validation of abnormal repetitive behaviors in mice: an illustration of the 4P's modeling approach. Behav. Brain Res. 2011, 219:189-196.
91. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
92. Gilby K.L., O'Brien T.J. Epilepsy, autism, and neurodevelopment: kindling a shared vulnerability?. Epilepsy Behav. 2013, 26:370-374.
93. Gillott A., Furniss F., Walter A. Anxiety in high-functioning children with autism. Autism 2001, 5:277-286.
94. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
95. Godar S.C., Mosher L.J., Strathman H.J., Gochi A.M., Jones C.M., Fowler S.C., Bortolato M. D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement. Br. J. Pharmacol. 2015, (in press).
96. Goldman S., Wang C., Salgado M.W., Greene P.E., Kim M., Rapin I. Motor stereotypies in children with autism and other developmental disorders. Dev. Med. Child Neurol. 2009, 51:30-38.
97. Gonzalez-Mantilla A.J., Moreno-De-Luca A., Ledbetter D.H., Martin C.L. A cross-disorder method to identify novel candidate genes for developmental brain disorders. JAMA Psychiatry 2016, 73(3):275-283.
98. Gormanns P., Mueller N.S., Ditzen C., Wolf S., Holsboer F., Turck C.W. Phenome-transcriptome correlation unravels anxiety and depression related pathways. J. Psychiatr. Res. 2011, 45:973-979.
99. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
100. Gottesman I.I., McGue M. Endophenotype. Encyclopedia of Clinical Psychology 2016, 1-23. Wiley-Blackwell, Hoboken, NJ. R. Cautin, S. Lilienfeld (Eds.).
101. Gould T.D., Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav. 2006, 5:113-119.
102. Greco B., Manago F., Tucci V., Kao H.T., Valtorta F., Benfenati F. Autism-related behavioral abnormalities in synapsin knockout mice. Behav. Brain Res. 2013, 251:65-74.
103. Green J., Collins C., Kyzar E.J., Pham M., Roth A., Gaikwad S., Cachat J., Stewart A.M., Landsman S., Grieco F., Tegelenbosch R., Noldus L.P., Kalueff A.V. Automated high-throughput neurophenotyping of zebrafish social behavior. J. Neurosci. Methods 2012, 210:266-271.
104. Griebel G., Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat. Rev. Drug Discov. 2013, 12:667-687.
105. Guariglia S.R., Chadman K.K. Water T-maze: a useful assay for determination of repetitive behaviors in mice. J. Neurosci. Methods 2013, 220:24-29.
106. Guilmatre A., Huguet G., Delorme R., Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. Dev. Neurobiol. 2014, 74:113-122.
107. Hahn M.E., Karkowski L., Weinreb L., Henry A., Schanz N., Hahn E.M. Genetic and developmental influences on infant mouse ultrasonic calling. II. Developmental patterns in the calls of mice 2-12 days of age. Behav. Genetics 1998, 28:315-325.
108. Hamilton S.M., Spencer C.M., Harrison W.R., Yuva-Paylor L.A., Graham D.F., Daza R.A., Hevner R.F., Overbeek P.A., Paylor R. Multiple autism-like behaviors in a novel transgenic mouse model. Behav. Brain Res. 2011, 218:29-41.
109. Hansen R.L., Rogers S.J., Publishing A.P. Autism and Other Neurodevelopmental Disorders 2013, American Psychiatric Association (APA).
110. Hara H. Autism and epilepsy: a retrospective follow-up study. Brain Dev. 2007, 29:486-490.
111. Hebb D.O., Williams K. A method of rating animal intelligence. J. Gen. Psychol. 1946, 34:59-65.
112. Hendley E.D., Ohlsson W.G. Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats. Am. J. Physiol. 1991, 261:H583-H589.
113. Hess E.J., Collins K.A., Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci. 1996, 16:3104-3111.
114. Holmes A., Murphy D.L., Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002, 161:160-167.
115. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003, 28:2077-2088.
116. Homberg J.R., Pattij T., Janssen M.C., Ronken E., De Boer S.F., Schoffelmeer A.N., Cuppen E. Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility. Eur. J. Neurosci. 2007, 26:2066-2073.
117. Homberg J.R., Schiepers O.J., Schoffelmeer A.N., Cuppen E., Vanderschuren L.J. Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology (Berl) 2007, 195:175-182.
118. Homberg J.R., Schubert D., Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 2010, 31:60-65.
119. Homberg J.R., Kyzar E.J., Stewart A.M., Nguyen M., Poudel M.K., Echevarria D.J., Collier A.D., Gaikwad S., Klimenko V.M., Norton W., Pittman J., Nakamura S., Koshiba M., Yamanouchi H., Apryatin S.A., Scattoni M.L., Diamond D.M., Ullmann J.F., Parker M.O., Brown R.E., Song C., Kalueff A.V. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies. Expert Opin. Drug Discov. 2015.
120. Homberg J.R. The stress-coping (mis)match hypothesis for nature x nurture interactions. Brain Res. 2012, 1432:114-121.
121. Hu W.F., Chahrour M.H., Walsh C.A. The diverse genetic landscape of neurodevelopmental disorders. Annu. Rev. Genomics Hum. Genet. 2014, 15:195-213.
122. Huang J., Zhong Z., Wang M., Chen X., Tan Y., Zhang S., He W., He X., Huang G., Lu H., Wu P., Che Y., Yan Y.L., Postlethwait J.H., Chen W., Wang H. Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior. J. Neurosci. 2015, 35:2572-2587.
123. Hunsaker M.R. Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders. Prog. Neurobiol. 2012, 96:220-241.
124. Ikeda M., Okahisa Y., Aleksic B., Won M., Kondo N., Naruse N., Aoyama-Uehara K., Sora I., Iyo M., Hashimoto R., Kawamura Y., Nishida N., Miyagawa T., Takeda M., Sasaki T., Tokunaga K., Ozaki N., Ujike H., Iwata N. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology 2013, 38:1864-1870.
125. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167:748-751.
126. Insel T.R. The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am. J. Psychiatry 2014, 171:395-397.
127. Iverson J.M., Braddock B.A. Gesture and motor skill in relation to language in children with language impairment. J. Speech Lang. Hear. Res. 2013, 54:72-86.
128. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neurosci. Biobehav. Rev. 2010, 34:897-921.
129. Jaber M., Dumartin B., Sagne C., Haycock J.W., Roubert C., Giros B., Bloch B., Caron M.G. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 1999, 11:3499-3511.
130. Jaffee S.R., Price T.S. Gene-environment correlations: a review of the evidence and implications for prevention of mental illness. Mol. Psychiatry 2007, 12:432-442.
131. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., Ramanantsoa N., Gallego J., Ronnenberg A., Winter D., Frahm J., Fischer J., Bourgeron T., Ehrenreich H., Brose N. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1710-1715.
132. Jeste S.S. The neurology of autism spectrum disorders. Curr. Opin. Neurol. 2011, 24:132-139.
133. Jones M.D., Williams M.E., Hess E.J. Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant. Pharmacol. Biochem. Behav. 2001, 68:669-676.
134. Kalueff A.V., Stewart A.M. Modeling neuropsychiatric spectra to empower translational biological psychiatry. Behav. Brain Res. 2015, 276:1-7.
135. Kalueff A.V., Tuohimaa P. Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice. Brain Res. 2004, 1028:75-82.
136. Kalueff A.V., Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain Res. Brain Res. Protoc. 2004, 13:151-158.
137. Kalueff A.V., Tuohimaa P. Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB/c and NMRI). Behav. Brain Res. 2005, 160:1-10.
138. Kalueff A.V., Tuohimaa P. The Suok (ropewalking) murine test of anxiety. Brain Res. Brain Res. Protoc. 2005, 14:87-99.
139. Kalueff A.V., Lou Y.R., Laaksi I., Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res. Bull. 2004, 64:25-29.
140. Kalueff A.V., Minasyan A., Keisala T., Shah Z.H., Tuohimaa P. Hair barbering in mice: implications for neurobehavioural research. Behav. Process. 2006, 71:8-15.
141. Kalueff A.V., Aldridge J.W., LaPorte J.L., Murphy D.L., Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nat. Protoc. 2007, 2:2538-2544.
142. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav. 2007, 6:389-400.
143. Kalueff A.V., Ren-Patterson R.F., Murphy D.L. The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends Pharmacol. Sci. 2007, 28:122-127.
144. Kalueff A.V., Wheaton M., Murphy D.L. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav. Brain Res. 2007, 179:1-18.
145. Kalueff A.V., Keisala T., Minasyan A., Kumar S.R., LaPorte J.L., Murphy D.L., Tuohimaa P. The regular and light-dark Suok tests of anxiety and sensorimotor integration: utility for behavioral characterization in laboratory rodents. Nat. Protoc. 2008, 3:129-136.
146. Kalueff A.V., Ren-Patterson R.F., LaPorte J.L., Murphy D.L. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for high-throughput neurophenotyping research. Behav. Brain Res. 2008, 188:243-249.
147. Kalueff A.V., Olivier J.D., Nonkes L.J., Homberg J.R. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci. Biobehav. Rev. 2010, 34:373-386.
148. Kalueff A.V., Gebhardt M., Stewart A.M., Cachat J.M., Brimmer M., Chawla J.S., Craddock C., Kyzar E.J., Roth A., Landsman S., Gaikwad S., Robinson K., Baatrup E., Tierney K., Shamchuk A., Norton W., Miller N., Nicolson T., Braubach O., Gilman C.P., Pittman J., Rosemberg D.B., Gerlai R., Echevarria D., Lamb E., Neuhauss S.C., Weng W., Bally-Cuif L., Schneider H., Zebrafish Neuroscience Research Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 2013, 10:70-86.
149. Kalueff A.V., Echevarria D.J., Stewart A.M. Gaining translational momentum: more zebrafish models for neuroscience research. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 55:1-6.
150. Kalueff A.V., Stewart A.M., Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 2014, 35:63-75.
151. Kalueff A.V., Stewart A.M., Gottesman I.I. Rethinking CNS disorders: time for new drug targets?. Trends Pharmacol. Sci. 2014, 35:491-492.
152. Kalueff A.V., Stewart A.M., Song C., Gottesman I.I. Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: translational lessons from preclinical models. Neurosci. Biobehav. Rev. 2015, 53:25-36.
153. Kalueff A.V., Stewart A.M., Song C., Berridge K.C., Graybiel A.M., Fentress J.C. Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat. Rev. Neurosci. 2016, 17(1):45-59.
154. Kaneko T., Mashimo T. Creating knockout and knockin rodents using engineered endonucleases via direct embryo injection. Methods Mol. Biol. 2015, 1239:307-315.
155. Karino G.M.T., Nakamura S., Kunikata T., Yamanouchi H., Koshiba M. Timing of changes from a primitive reflex to a voluntary behavior in infancy as a potential predictor of socio-psychological and physical development during juvenile stages among common marmosets. J. King Saud Univ. Sci. 2015, 27:260-270.
156. Karvat G., Kimchi T. Systematic autistic-like behavioral phenotyping of 4 mouse strains using a novel wheel-running assay. Behav. Brain Res. 2012, 233:405-414.
157. Karvat G., Kimchi T. Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Neuropsychopharmacology 2014, 39:831-840.
158. Kaur K., Simon A.F., Chauhan V., Chauhan A. Effect of bisphenol A on Drosophila melanogaster behavior-a new model for the studies on neurodevelopmental disorders. Behav. Brain Res. 2015, 284:77-84.
159. Kiser D., Steemers B., Branchi I., Homberg J.R. The reciprocal interaction between serotonin and social behaviour. Neurosci. Biobehav. Rev. 2012, 36:786-798.
160. Knutson B., Burgdorf J., Panksepp J. Ultrasonic vocalizations as indices of affective states in rats. Psychol. Bull. 2002, 128:961-977.
161. Korff S., Harvey B.H. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Psychiatr. Clin. North Am. 2006, 29:371-390.
162. Koshiba M., Mimura K., Sugiura Y., Okuya T., Senoo A., Ishibashi H., Nakamura S. Reading marmoset behavior 'semantics' under particular social context by multi-parameters correlation analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1499-1504.
163. Koshiba M., Karino G., Senoo A., Mimura K., Shirakawa Y., Fukushima Y., Obara S., Sekihara H., Ozawa S., Ikegami K., Ueda T., Yamanouchi H., Nakamura S. Peer attachment formation by systemic redox regulation with social training after a sensitive period. Sci. Rep. 2013, 3:2503.
164. Koshiba M., Senoo A., Mimura K., Shirakawa Y., Karino G., Obara S., Ozawa S., Sekihara H., Fukushima Y., Ueda T., Kishino H., Tanaka T., Ishibashi H., Yamanouchi H., Yui K., Nakamura S. A cross-species socio-emotional behaviour development revealed by a multivariate analysis. Sci. Rep. 2013, 3.
165. Koshiba M., Shirakawa Y., Mimura K., Senoo A., Karino G., Nakamura S. Familiarity perception call elicited under restricted sensory cues in peer-social interactions of the domestic chick. PLoS One 2013, 8:e58847.
166. Koshiba M.N.S., Mimura K., Senoo A., Karino G., Amemiya S., Miyaji T., Kunikata T., Yamanouchi H. Socio-emotional development evaluated by behaviour output analysis for quantitative emotional state translation: towards early diagnosis of individuals with developmental disorders. OA Autism 2013, 1:18.
167. Koshiba M., Kakei H., Honda M., Karino G., Niitsu M., Miyaji T., Kishino H., Nakamura S., Kunikata T., Yamanouchi H. Early-infant diagnostic predictors of the neuro-behavioral development after neonatal care. Behav. Brain Res. 2015, 276:143-150.
168. Koshiba M., Senoo A., Karino G., Ozawa S., Tanaka I., Honda Y., Usui S., Kodama T., Mimura K., Nakamura S., Kunikata T., Yamanouchi H., Tokuno H. Susceptible period of socio-emotional development affected by constant exposure to daylight. Neurosci. Res. 2015, 93:91-98.
169. Kriegebaum C., Gutknecht L., Schmitt A., Lesch K.P., Reif A. Serotonin now: part 1. neurobiology and developmental genetics. Fortschr. Neurol. Psychiatr. 2010, 78:319-331.
170. Krishnan K.R. Psychiatric and medical comorbidities of bipolar disorder. Psychosom. Med. 2005, 67:1-8.
171. Kullyev A., Dempsey C.M., Miller S., Kuan C.J., Hapiak V.M., Komuniecki R.W., Griffin C.T., Sze J.Y. A genetic survey of fluoxetine action on synaptic transmission in Caenorhabditis elegans. Genetics 2010, 186:929-941.
172. LaPorte J.L., Egan R.J., Hart P.C., Bergner C.L., Cachat J.M., Canavello P.R., Kalueff A.V. Qui non proficit, deficit: experimental models for 'integrative' research of affective disorders. J. Affect. Disord. 2010, 121:1-9.
173. Lahvis G., Black L. Social interactions in the clinic and the cage: toward a more valid mouse model of autism. Animal Models of Behavioral Analysis. Neuromethods 2011, 153-192. J. Raber (Ed.).
174. Lange M., Norton W., Coolen M., Chaminade M., Merker S., Proft F., Schmitt A., Vernier P., Lesch K.P., Bally-Cuif L. The ADHD-linked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish. Mol. Psychiatry 2012, 17:855.
175. Lange M., Norton W., Coolen M., Chaminade M., Merker S., Proft F., Schmitt A., Vernier P., Lesch K.P., Bally-Cuif L. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry 2012, 17:946-954.
176. Le Strat Y., Ramoz N., Gorwood P. The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia. Curr. Mol. Med. 2009, 9:506-518.
177. LeBarton E.S., Iverson J.M. Fine motor skill predicts expressive language in infant siblings of children with autism. Dev. Sci. 2013, 16:815-827.
178. Lee P.C., Dodart J.C., Aron L., Finley L.W., Bronson R.T., Haigis M.C., Yankner B.A., Harper J.W. Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system. Mol. Cell 2013, 50:172-184.
179. Lenzenweger M.F. Thinking clearly about the endophenotype-intermediate phenotype-biomarker distinctions in developmental psychopathology research. Dev. Psychopathol. 2013, 25:1347-1357.
180. Leonard H.C., Bedford R., Charman T., Elsabbagh M., Johnson M.H., Hill E.L. Motor development in children at risk of autism: a follow-up study of infant siblings. Autism 2013, 18:281-291.
181. Lesch K.P., Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 2012, 76:175-191.
182. Lewis M.H., Tanimura Y., Lee L.W., Bodfish J.W. Animal models of restricted repetitive behavior in autism. Behav. Brain Res. 2007, 176:66-74.
183. Lonetti G., Angelucci A., Morando L., Boggio E.M., Giustetto M., Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry 2010, 67:657-665.
184. Lopez-Patino M.A., Yu L., Cabral H., Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol. Behav. 2008, 93:160-171.
185. Luthman J., Fredriksson A., Sundstrom E., Jonsson G., Archer T. Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav. Brain Res. 1989, 33:267-277.
186. Maccarrone G., Ditzen C., Yassouridis A., Rewerts C., Uhr M., Uhlen M., Holsboer F., Turck C.W. Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters. J. Psychiatr. Res. 2013, 47:1572-1580.
187. Macri S., Onori M.P., Roessner V., Laviola G. Animal models recapitulating the multifactorial origin of Tourette syndrome. Int. Rev. Neurobiol. 2013, 112:211-237.
188. Macri S., Proietti Onori M., Laviola G. Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome. Neurosci. Biobehav. Rev. 2013, 37:1085-1100.
189. Martinez-Cue C., Rueda N., Garcia E., Florez J. Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome. Genes Brain Behav. 2006, 5:413-422.
190. Martino D., Laviola G. The multifaceted nature of Tourette syndrome: pre-clinical, clinical and therapeutic issues. Neurosci. Biobehav. Rev. 2013, 37:993-996.
191. McAlonan K., Brown V.J. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav. Brain Res. 2003, 146:97-103.
192. McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J., Crawley J.N. Autism-like behavioral phenotypes in BTBR T + tf/J mice. Genes Brain Behav. 2008, 7:152-163.
193. McNamara M.C., Benignus G., Benignus V.A., Miller A.T. Active and passive avoidance in rats as a function of age. Exp. Aging Res. 1977, 3:3-16.
194. Miceli S., Negwer M., van Eijs F., Kalkhoven C., van Lierop I., Homberg J., Schubert D. High serotonin levels during brain development alter the structural input-output connectivity of neural networks in the rat somatosensory layer IV. Front. Cell. Neurosci. 2013, 7:88.
195. Michetti C.R.L., Scattoni M.L. Modeling social communication deficits in mouse models of autism. Autism 2012, S1:007.
196. Miller N., Greene K., Dydinski A., Gerlai R. Effects of nicotine and alcohol on zebrafish (Danio rerio) shoaling. Behav. Brain Res. 2013, 240:192-196.
197. Mimura K., Nakamura S., Koshiba M. A flexion period for attachment formation in isolated chicks to unfamiliar peers visualized in a developmental trajectory space through behavioral multivariate correlation analysis. Neurosci. Lett. 2013, 547:70-75.
198. Mimura K.M.M., Nakamura S., Koshiba M. A sensitive period of peer-social learning. J. Clin. Toxicol. 2013, 3:000158.
199. Mimura K., Kishino H., Karino G., Nitta E., Senoo A., Ikegami K., Kunikata T., Yamanouchi H., Nakamura S., Sato K., Koshiba M. Potential of a smartphone as a stress-free sensor of daily human behaviour. Behav. Brain Res. 2015, 276:181-189.
200. Moles A., Costantini F., Garbugino L., Zanettini C., D'Amato F.R. Ultrasonic vocalizations emitted during dyadic interactions in female mice: a possible index of sociability?. Behav. Brain Res. 2007, 182:223-230.
201. Mook D.M., Jeffrey J., Neuringer A. Spontaneously hypertensive rats (SHR) readily learn to vary but not repeat instrumental responses. Behav. Neural Biol. 1993, 59:126-135.
202. Morand-Beaulieu S., O'Connor K.P., Sauve G., Blanchet P.J., Lavoie M.E. Cognitive-behavioral therapy induces sensorimotor and specific electrocortical changes in chronic tic and Tourette's disorder. Neuropsychologia 2015, 79:310-321.
203. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
204. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 1996, 16:1337-1345.
205. Moser V.C., McCormick J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 1988, 11:189-206.
206. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004, 3:287-302.
207. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Barbaro J.R., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., Crawley J.N. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 2007, 176:4-20.
208. Moy S.S., Nadler J.J., Poe M.D., Nonneman R.J., Young N.B., Koller B.H., Crawley J.N., Duncan G.E., Bodfish J.W. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav. Brain Res. 2008, 188:178-194.
209. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9:85-96.
210. Myers M.M., Musty R.E., Hendley E.D. Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav. Neural Biol. 1982, 34:42-54.
211. Nadler J.J., Moy S.S., Dold G., Trang D., Simmons N., Perez A., Young N.B., Barbaro R.P., Piven J., Magnuson T.R., Crawley J.N. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. 2004, 3:303-314.
212. Nagy Z.M., Pagano M., Gable D. Differential development of 24-h retention capacities for two components of T-maze escape learning by infant mice. Anim. Learn. Behav. 1976, 4:25-29.
213. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
214. Nordstrom E.J., Bittner K.C., McGrath M.J., Parks C.R., Burton F.H. Hyperglutamatergic cortico-striato-thalamo-cortical circuit breaker drugs alleviate tics in a transgenic circuit model of Tourettes syndrome. Brain Res. 2015, 1629:38-53.
215. Norton W. Measuring larval zebrafish behavior: locomotion, thigmotaxis and startle. Zebrafish Neurobehav. Protoc. 2011, 2.
216. Nyby J. Ultrasonic vocalizations during sex behavior of male house mice (Mus musculus): a description. Behav. Neural Biol. 1983, 39:128-134.
217. Nyby J.G. Auditory communication among adults. Handbook of Mouse Auditory Research: from Behavior to Molecular Biology 2001, 3-18. CRC, New York. J.F. Willott (Ed.).
218. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963, 27:282-293.
219. Panksepp J. Can anthropomorphic analyses of separation cries in other animals inform us about the emotional nature of social loss in humans? Comment on Blumberg and Sokoloff (2001). Psychol. Rev. 2001, 110:376-388. (discussion 389-396).
220. Parker M.O., Millington M.E., Combe F.J., Brennan C.H. Development and implementation of a three-choice serial reaction time task for zebrafish (Danio rerio). Behav. Brain Res. 2012, 227:73-80.
221. Parker C.C., Chen H., Flagel S.B., Geurts A.M., Richards J.B., Robinson T.E., Solberg Woods L.C., Palmer A.A. Rats are the smart choice: rationale for a renewed focus on rats in behavioral genetics. Neuropharmacology 2014, 76(Pt. B):250-258.
222. Parker M.O., Annan L.V., Kanellopoulos A.H., Brock A.J., Combe F.J., Baiamonte M., Teh M.T., Brennan C.H. The utility of zebrafish to study the mechanisms by which ethanol affects social behavior and anxiety during early brain development. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 55:94-100.
223. Parker M.O., Brock A.J., Sudwarts A., Brennan C.H. Atomoxetine reduces anticipatory responding in a 5-choice serial reaction time task for adult zebrafish. Psychopharmacology (Berl.) 2014, 231:2671-2679.
224. Pearson B.L., Pobbe R.L., Defensor E.B., Oasay L., Bolivar V.J., Blanchard D.C., Blanchard R.J. Motor and cognitive stereotypies in the BTBR T + tf/J mouse model of autism. Genes Brain Behav. 2011, 10:228-235.
225. Pearson B.L., Bettis J.K., Meyza K.Z., Yamamoto L.Y., Blanchard D.C., Blanchard R.J. Absence of social conditioned place preference in BTBR T + tf/: J mice: relevance for social motivation testing in rodent models of autism. Behav. Brain Res. 2012, 233:99-104.
226. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
227. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
228. Penagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
229. Perry W., Minassian A., Paulus M.P., Young J.W., Kincaid M.J., Ferguson E.J., Henry B.L., Zhuang X., Masten V.L., Sharp R.F., Geyer M.A. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch. Gen. Psychiatry 2009, 66:1072-1080.
230. Perry W., Minassian A., Henry B., Kincaid M., Young J.W., Geyer M.A. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res. 2010, 178:84-91.
231. Persico A.M., Mengual E., Moessner R., Hall F.S., Revay R.S., Sora I., Arellano J., DeFelipe J., Gimenez-Amaya J.M., Conciatori M., Marino R., Baldi A., Cabib S., Pascucci T., Uhl G.R., Murphy D.L., Lesch K.P., Keller F. Barrel pattern formation requires serotonin uptake by thalamocortical afferents: and not vesicular monoamine release. J. Neurosci. 2001, 21:6862-6873.
232. Phagava H., Muratori F., Einspieler C., Maestro S., Apicella F., Guzzetta A., Prechtl H.F., Cioni G. General movements in infants with autism spectrum disorders. Georgian Med. News 2008, 100-105.
233. Pinto L.H., Enroth-Cugell C. Tests of the mouse visual system. Mamm. Genome 2000, 11:531-536.
234. Pogorelov V.M., Rodriguiz R.M., Insco M.L., Caron M.G., Wetsel W.C. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 2005, 30:1818-1831.
235. Porrino L.J., Rapoport J.L., Behar D., Sceery W., Ismond D.R., Bunney W.E. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch. Gen. Psychiatry 1983, 40:681-687.
236. Pritchett K., Mulder G. Hebb-williams mazes. Contemp. Top Lab. Anim. Sci. 2004, 43:44-45.
237. Raber J., Mehta P.P., Kreifeldt M., Parsons L.H., Weiss F., Bloom F.E., Wilson M.C. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J. Neurochem. 1997, 68:176-186.
238. Radyushkin K., Hammerschmidt K., Boretius S., Varoqueaux F., El-Kordi A., Ronnenberg A., Winter D., Frahm J., Fischer J., Brose N., Ehrenreich H. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav. 2009, 8:416-425.
239. Rapanelli M., Pittenger C. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology 2015, S0028-3908:30065-30066.
240. Rebello T.J., Yu Q., Goodfellow N.M., Caffrey Cagliostro M.K., Teissier A., Morelli E., Demireva E.Y., Chemiakine A., Rosoklija G.B., Dwork A.J., Lambe E.K., Gingrich J.A., Ansorge M.S. Postnatal day 2-11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J. Neurosci. 2014, 34:12379-12393.
241. Redei E.E., Ahmadiyeh N., Baum A.E., Sasso D.A., Slone J.L., Solberg L.C., Will C.C., Volenec A. Novel animal models of affective disorders. Semin. Clin. Neuropsychiatry 2001, 6:43-67.
242. Reiter L. An introduction to neurobehavioral toxicology. Environ. Health Perspect. 1978, 26:5-7.
243. Restivo L., Ferrari F., Passino E., Sgobio C., Bock J., Oostra B.A., Bagni C., Ammassari-Teule M. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11557-11562.
244. Reynolds S., Urruela M., Devine D.P. Effects of environmental enrichment on repetitive behaviors in the BTBR T + tf/: J mouse model of autism. Autism Res. 2013, 6:337-343.
245. Ricceri L., Moles A., Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav. Brain Res. 2007, 176:40-52.
246. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 2000, 108:511-533.
247. Romano E., Michetti C., Caruso A., Laviola G., Scattoni M.L. Characterization of neonatal vocal and motor repertoire of reelin mutant mice. PLoS One 2013, 8:e64407.
248. Roubertoux P.L., Baumann L., Ragueneau S., Semal C. Early development in mice. IV. Age at disappearance of the rooting response: genetic analysis in newborn mice. Behav. Genet. 1987, 17:453-464.
249. Roubertoux P.L., Martin B., Le Roy I., Beau J., Marchaland C., Perez-Diaz F., Cohen-Salmon C., Carlier M. Vocalizations in newborn mice: genetic analysis. Behav. Genet. 1996, 26:427-437.
250. Roullet F.I., Crawley J.N. Mouse models of autism: testing hypotheses about molecular mechanisms. Curr. Top. Behav. Neurosci. 2011, 7:187-212.
251. Roy S., Watkins N., Heck D. Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile x syndrome reveals limited, call type specific deficits. PLoS One 2012, 7:e44816.
252. Russell V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav. Brain Res. 2002, 130:191-196.
253. Sadler T.W. Langman's Medical Embryology 2006, Lippincott Williams & Wilkins.
254. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 1992, 58:103-112.
255. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 2000, 24:31-39.
256. Sagvolden T. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of attention-deficit/hyperactivity disorder (ADHD). Behav. Brain Funct. 2006, 2:41.
257. Saili K.S., Corvi M.M., Weber D.N., Patel A.U., Das S.R., Przybyla J., Anderson K.A., Tanguay R.L. Neurodevelopmental low-dose bisphenol A exposure leads to early life-stage hyperactivity and learning deficits in adult zebrafish. Toxicology 2012, 291:83-92.
258. Sala M., Braida D., Lentini D., Busnelli M., Bulgheroni E., Capurro V., Finardi A., Donzelli A., Pattini L., Rubino T., Parolaro D., Nishimori K., Parenti M., Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 2011, 69:875-882.
259. Sala M., Braida D., Donzelli A., Martucci R., Busnelli M., Bulgheroni E., Rubino T., Parolaro D., Nishimori K., Chini B. Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-)) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. J. Neuroendocrinol. 2013, 25:107-118.
260. Sales G.D. Ultrasound and aggressive behaviour in rats and other small mammals. Anim. Behav. 1972, 20:88-100.
261. Sansa G., Carlson C., Doyle W., Weiner H.L., Bluvstein J., Barr W., Devinsky O. Medically refractory epilepsy in autism. Epilepsia 2011, 52:1071-1075.
262. Scattoni M.L., Gandhy S.U., Ricceri L., Crawley J.N. Unusual repertoire of vocalizations in the BTBR T + tf/J mouse model of autism. PLoS One 2008, 3:e3067.
263. Scattoni M.L., Crawley J., Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci. Biobehav. Rev. 2009, 33:508-515.
264. Scattoni M.L., Ricceri L., Crawley J.N. Unusual repertoire of vocalizations in adult BTBR T + tf/J mice during three types of social encounters. Genes Brain Behav. 2011, 10:44-56.
265. Scheggia D., Bebensee A., Weinberger D.R., Papaleo F. The ultimate intra-/extra-dimensional attentional set-shifting task for mice. Biol. Psychiatry 2014, 75:660-670.
266. Schmeisser M.J., Ey E., Wegener S., Bockmann J., Stempel A.V., Kuebler A., Janssen A.L., Udvardi P.T., Shiban E., Spilker C., Balschun D., Skryabin B.V., Dieck S., Smalla K.H., Montag D., Leblond C.S., Faure P., Torquet N., Le Sourd A.M., Toro R., Grabrucker A.M., Shoichet S.A., Schmitz D., Kreutz M.R., Bourgeron T., Gundelfinger E.D., Boeckers T.M. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 2012, 486:256-260.
267. Schmeisser M.J. Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. Ann. Anat. 2015, 200:115-117.
268. Seibt K.J., Oliveira Rda L., Zimmermann F.F., Capiotti K.M., Bogo M.R., Ghisleni G., Bonan C.D. Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav. Brain Res. 2010, 214:417-422.
269. Senoo A., Okuya T., Sugiura Y., Mimura K., Honda Y., Tanaka I., Kodama T., Tokuno H., Yui K., Nakamura S., Usui S., Koshiba M. Effects of constant daylight exposure during early development on marmoset psychosocial behavior. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1493-1498.
270. Sewell G.D. Ultrasonic communication in rodents. Nature 1970, 227:410.
271. Shair H.N., Brunelli S.A., Masmela J.R., Boone E., Hofer M.A. Social, thermal, and temporal influences on isolation-induced and maternally potentiated ultrasonic vocalizations of rat pups. Dev. Psychobiol. 2003, 42:206-222.
272. Shirakawa Y.N.S., Koshiba M. Peer-social network development revealed by the brain multivariate correlation map with 10 monoamines and 11 behaviors. J. Clin. Toxicol. 2013, 3:1000161.
273. Shirakawa Y.M., Senoo K., Fujii A., Shimizu K., Saga T., Tanaka T., Honda I., Tokuno Y., Hironobu Usui S., Kodama T., Tsugawa W., Sode K., Nakamura S., Koshiba M. Multivariate correlation analysis suggested high ubiquinol and low ubiquinone in plasma promoted primates' social motivation and IR detected lower body temperature. J. Clin. Toxicol. 2013, 3:1000160.
274. Silverman J.L., Crawley J.N. The promising trajectory of autism therapeutics discovery. Drug Discov. Today 2014, 19:838-844.
275. Silverman J.L., Tolu S.S., Barkan C.L., Crawley J.N. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 2010, 35:976-989.
276. Silverman J.L., Yang M., Lord C., Crawley J.N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 2010, 11:490-502.
277. Silverman J.L., Smith D.G., Rizzo S.J., Karras M.N., Turner S.M., Tolu S.S., Bryce D.K., Smith D.L., Fonseca K., Ring R.H., Crawley J.N. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci. Transl. Med. 2012, 4:131ra151.
278. Simpson K.L., Weaver K.J., de Villers-Sidani E., Lu J.Y., Cai Z., Pang Y., Rodriguez-Porcel F., Paul I.A., Merzenich M., Lin R.C. Perinatal antidepressant exposure alters cortical network function in rodents. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18465-18470.
279. Smit-Rigter L.A., Noorlander C.W., von Oerthel L., Chameau P., Smidt M.P., van Hooft J.A. Prenatal fluoxetine exposure induces life-long serotonin 5-HT(3) receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 2012, 62:865-870.
280. Sontag T.A., Tucha O., Walitza S., Lange K.W. Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review. Atten. Defic. Hyperact. Disord. 2010, 2:1-20.
281. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7699-7704.
282. Spencer C.M., Alekseyenko O., Serysheva E., Yuva-Paylor L.A., Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 2005, 4:420-430.
283. Stewart A.M., Kalueff A.V. Developing better and more valid animal models of brain disorders. Behav. Brain Res. 2015, 276:28-31.
284. Stewart A.M., Braubach O., Spitsbergen J., Gerlai R., Kalueff A.V. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci. 2014, 37:264-278.
285. Stewart A.M., Nguyen M., Wong K., Poudel M.K., Kalueff A.V. Developing zebrafish models of autism spectrum disorder (ASD). Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 50:27-36.
286. Stewart A.M., Gerlai R., Kalueff A.V. Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery. Front. Behav. Neurosci. 2015, 9:14.
287. Stewart A.M., Grieco F., Tegelenbosch R.A., Kyzar E.J., Nguyen M., Kaluyeva A., Song C., Noldus L.P., Kalueff A.V. A novel 3D method of locomotor analysis in adult zebrafish: implications for automated detection of CNS drug-evoked phenotypes. J. Neurosci. Methods 2015, 255:66-74.
288. Stewart A.M., Nguyen M., Song C., Kalueff A.V. Understanding the genetic architectonics of complex CNS traits: lost by the association, but found in the interaction. J. Psychopharmacol. 2015, 29:872-877.
289. Stewart A.M., Ullmann J.F., Norton W.H., Parker M.O., Brennan C.H., Gerlai R., Kalueff A.V. Molecular psychiatry of zebrafish. Mol. Psychiatry 2015, 20:2-17.
290. Sullivan R.M., Wilson D.A. Dissociation of behavioral and neural correlates of early associative learning. Dev. Psychobiol. 1995, 28:213-219.
291. Sungur A.O., Vorckel K.J., Schwarting R.K., Wohr M. Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context. J. Neurosci. Methods 2014, 234:92-100.
292. Tait D.S., Chase E.A., Brown V.J. Attentional set-shifting in rodents: a review of behavioural methods and pharmacological results. Curr. Pharm. Des. 2014, 20:5046-5059.
293. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl.) 2009, 204:361-373.
294. Turner C.A., Presti M.F., Newman H.A., Bugenhagen P., Crnic L., Lewis M.H. Spontaneous stereotypy in an animal model of Down syndrome: ts65Dn mice. Behav. Genet. 2001, 31:393-400.
295. Tyzio R., Nardou R., Ferrari D.C., Tsintsadze T., Shahrokhi A., Eftekhari S., Khalilov I., Tsintsadze V., Brouchoud C., Chazal G., Lemonnier E., Lozovaya N., Burnashev N., Ben-Ari Y. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science (New York, N.Y) 2014, 343:675-679.
296. Ullmann J.F., Cowin G., Kurniawan N.D., Collin S.P. A three-dimensional digital atlas of the zebrafish brain. Neuroimage 2010, 51:76-82.
297. Ullmann J.F., Calamante F., Collin S.P., Reutens D.C., Kurniawan N.D. Enhanced characterization of the zebrafish brain as revealed by super-resolution track-density imaging. Brain Struct. Funct. 2015, 220:457-468.
298. Van Raamsdonk J.M., Pearson J., Slow E.J., Hossain S.M., Leavitt B.R., Hayden M.R. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 2005, 25:4169-4180.
299. Van Schalkwyk G.I., Lewis A.S., Qayyum Z., Koslosky K., Picciotto M.R., Volkmar F.R. Reduction of aggressive episodes after repeated transdermal nicotine administration in a hospitalized adolescent with autism spectrum disorder. J. Autism Dev. Disord. 2015, 45:3061-3066.
300. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., Uhl G.R. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14:1104-1106.
301. Veenstra-VanderWeele J., Muller C.L., Iwamoto H., Sauer J.E., Owens W.A., Shah C.R., Cohen J., Mannangatti P., Jessen T., Thompson B.J., Ye R., Kerr T.M., Carneiro A.M., Crawley J.N., Sanders-Bush E., McMahon D.G., Ramamoorthy S., Daws L.C., Sutcliffe J.S., Blakely R.D. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5469-5474.
302. Viggiano D., Grammatikopoulos G., Sadile A.G. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav. Brain Res. 2002, 130:181-189.
303. Vorhees C.V., Butcher R.E., Brunner R.L., Sobotka T.J. A developmental test battery for neurobehavioral toxicity in rats: a preliminary analysis using monosodium glutamate calcium carrageenan, and hydroxyurea. Toxicol. Appl. Pharmacol. 1979, 50:267-282.
304. Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C., Kim C.J., Berrios J., Colvin J.S., Bousquet-Moore D., Lorenzo I., Wu G., Weinberg R.J., Ehlers M.D., Philpot B.D., Beaudet A.L., Wetsel W.C., Jiang Y.H. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 2011, 20:3093-3108.
305. Wecker J.R., Ison J.R., Foss J.A. Reflex modification as a test for sensory function. Neurobehav. Toxicol. Teratol. 1985, 7:733-738.
306. Wersinger S.R., Ginns E.I., O'Carroll A.M., Lolait S.J., Young W.S. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol. Psychiatry 2002, 7:975-984.
307. Wise A., Tenezaca L., Fernandez R.W., Schatoff E., Flores J., Ueda A., Zhong X., Wu C.F., Simon A.F., Venkatesh T. Drosophila mutants of the autism candidate gene neurobeachin (rugose) exhibit neuro-developmental disorders, aberrant synaptic properties, altered locomotion, and impaired adult social behavior and activity patterns. J. Neurogenet. 2015, 1-9.
308. Witteveen J.S., Middelman A., van Hulten J.A., Martens G.J., Homberg J.R., Kolk S.M. Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation. Front. Cell. Neurosci. 2013, 7:143.
309. Wohr M., Scattoni M.L. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments. Behav. Brain Res. 2013, 251:5-17.
310. Wohr M., Silverman J.L., Scattoni M.L., Turner S.M., Harris M.J., Saxena R., Crawley J.N. Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behav. Brain Res. 2012, 251:50-64.
311. Won H., Lee H.R., Gee H.Y., Mah W., Kim J.I., Lee J., Ha S., Chung C., Jung E.S., Cho Y.S., Park S.G., Lee J.S., Lee K., Kim D., Bae Y.C., Kaang B.K., Lee M.G., Kim E. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012, 486:261-265.
312. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005, 32:43-50.
313. Woolfenden S., Sarkozy V., Ridley G., Coory M., Williams K. A systematic review of two outcomes in autism spectrum disorder-epilepsy and mortality. Dev. Med. Child Neurol. 2012, 54:306-312.
314. Wurzman R., Forcelli P.A., Griffey C.J., Kromer L.F. Repetitive grooming and sensorimotor abnormalities in an ephrin-a knockout model for Autism Spectrum Disorders. Behav. Brain Res. 2014, 278C:115-128.
315. Wyss J.M., Fisk G., van Groen T. Impaired learning and memory in mature spontaneously hypertensive rats. Brain Res. 1992, 592:135-140.
316. Xu Y., Sari Y., Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 2004, 150:151-161.
317. Xu M., Kobets A., Du J.C., Lennington J., Li L., Banasr M., Duman R.S., Vaccarino F.M., DiLeone R.J., Pittenger C. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:893-898.
318. Xu M., Li L., Ohtsu H., Pittenger C. Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear. Neurosci. Lett. 2015, 595:50-53.
319. Yang M., Silverman J.L., Crawley J.N. Automated three-chambered social approach task for mice. Curr. Protoc. Neurosci. 2011, 8(26). (Chapter 8).
320. Yang M., Bozdagi O., Scattoni M.L., Wohr M., Roullet F.I., Katz A.M., Abrams D.N., Kalikhman D., Simon H., Woldeyohannes L., Zhang J.Y., Harris M.J., Saxena R., Silverman J.L., Buxbaum J.D., Crawley J.N. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J. Neurosci. 2012, 32:6525-6541.
321. Yu D., Mathews C.A., Scharf J.M., Neale B.M., Davis L.K., Gamazon E.R., Derks E.M., Evans P., Edlund C.K., Crane J., Fagerness J.A., Osiecki L., Gallagher P., Gerber G., Haddad S., Illmann C., McGrath L.M., Mayerfeld C., Arepalli S., Barlassina C., Barr C.L., Bellodi L., Benarroch F., Berrio G.B., Bienvenu O.J., Black D.W., Bloch M.H., Brentani H., Bruun R.D., Budman C.L., Camarena B., Campbell D.D., Cappi C., Silgado J.C., Cavallini M.C., Chavira D.A., Chouinard S., Cook E.H., Cookson M.R., Coric V., Cullen B., Cusi D., Delorme R., Denys D., Dion Y., Eapen V., Egberts K., Falkai P., Fernandez T., Fournier E., Garrido H., Geller D., Gilbert D.L., Girard S.L., Grabe H.J., Grados M.A., Greenberg B.D., Gross-Tsur V., Grunblatt E., Hardy J., Heiman G.A., Hemmings S.M., Herrera L.D., Hezel D.M., Hoekstra P.J., Jankovic J., Kennedy J.L., King R.A., Konkashbaev A.I., Kremeyer B., Kurlan R., Lanzagorta N., Leboyer M., Leckman J.F., Lennertz L., Liu C., Lochner C., Lowe T.L., Lupoli S., Macciardi F., Maier W., Manunta P., Marconi M., McCracken J.T., Mesa Restrepo S.C., Moessner R., Moorjani P., Morgan J., Muller H., Murphy D.L., Naarden A.L., Nurmi E., Ochoa W.C., Ophoff R.A., Pakstis A.J., Pato M.T., Pato C.N., Piacentini J., Pittenger C., Pollak Y., et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am. J. Psychiatry 2015, 172:82-93.
322. Zhang K., Hill K., Labak S., Blatt G.J., Soghomonian J.J. Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in mice. Neuroscience 2014, 275:238-247.
323. Zhao Y., Fung C., Shin D., Shin B.C., Thamotharan S., Sankar R., Ehninger D., Silva A., Devaskar S.U. Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders. Mol. Psychiatry 2010, 15:286-299.
324. Zhou J., Blundell J., Ogawa S., Kwon C.H., Zhang W., Sinton C., Powell C.M., Parada L.F. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 2009, 29:1773-1783.
325. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1982-1987.
326. Zikopoulos B., Barbas H. Changes in prefrontal axons may disrupt the network in autism. J. Neurosci. 2010, 30:14595-14609.
327. Zippelius H.M., Schleidt W.M. Ultraschall-laute bej jungen mausen (Ultrasonic vocalization in infant mice). Die Naturwissenschaften 1956, 43:502-503.
328. van Steensel F.J., Bogels S.M., Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin. Child Fam. Psychol. Rev. 2011, 14:302-317.
329. van den Bergh F.S., Bloemarts E., Chan J.S., Groenink L., Olivier B., Oosting R.S. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. Pharmacol. Biochem. Behav. 2006, 83:380-390.
330. van der Voet M., Harich B., Franke B., Schenck A. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila. Mol. Psychiatry 2015.